U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908356) titled 'An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures' on March 19.
Brief Summary: An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
Study Start Date: Jan. 10
Study Type: INTERVENTIONAL
Condition:
Focal Onset Seizure
Primary Generalized Epilepsy
Intervention:
DRUG: 30mg PRAX-628
Once daily oral
Recruitment Status: RECRUITING
Sponsor: Praxis Precision Medicines
Published by HT Digital Content Services with permission from Health Daily Digest....